Medifast(MED),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MED Medifast

Pre-Market Trading 11-05 06:40:09 EST

18.81

+0.23

+1.24%

High19.22	Low18.53	Vol206.34K
Open18.58	D1 Closing18.58	Amplitude3.71%
Mkt Cap200.35M	Tradable Cap177.57M	Total Shares10.65M
T/O3.90M	T/O Rate2.19%	Tradable Shares9.44M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"MED","market":"US","secType":"STK","nameCN":"Medifast","latestPrice":18.81,"timestamp":1730754000000,"preClose":18.58,"halted":0,"volume":206343,"delay":0,"floatShares":9440215,"shares":10651418,"eps":2.673478,"marketStatus":"Pre-Market Trading","change":0.23,"latestTime":"11-05 06:40:09 EST","open":18.58,"high":19.22,"low":18.5304,"amount":3900290.4337680005,"amplitude":0.037115,"askPrice":21.16,"askSize":100,"bidPrice":18.8,"bidSize":10,"shortable":3,"etf":0,"ttmEps":2.673478,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1730817000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":757227600000,"exchange":"NYSE","adjPreClose":18.81,"dividendRate":0.087719,"postHourTrading":{"tag":"盘后","latestPrice":19.15,"preClose":18.81,"latestTime":"19:38 EST","volume":8127,"amount":155463.78,"timestamp":1730767120467},"volumeRatio":1.3157968582075583,"impliedVol":0.8772,"impliedVolPercentile":0.8008},"requestUrl":"/m/hq/s/MED","defaultTab":"news","newsList":[{"id":"2481547614","title":"Medifast Inc reports results for the quarter ended in September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2481547614","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481547614?lang=en_us&edition=fundamental","pubTime":"2024-11-05 15:42","pubTimestamp":1730792570,"startTime":"0","endTime":"0","summary":"* Medifast Inc    reported quarterly adjusted earnings of 35 cents per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of $2.12.  The mea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MED"],"gpt_icon":0},{"id":"2481593658","title":"Medifast (MED) Beats Q3 Earnings and Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2481593658","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481593658?lang=en_us&edition=fundamental","pubTime":"2024-11-05 06:45","pubTimestamp":1730760307,"startTime":"0","endTime":"0","summary":"Medifast  came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of a loss of $0.15 per share. This compares to earnings of $2.12 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 333.33%. A quarter ago, it was expected that this weight-loss company would post earnings of $0.36 per share when it actually produced earnings of $0.92, delivering a surprise of 155.56%.Medifast , which belongs to the Zacks Food - Miscellaneous industry, posted revenues of $140.16 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 3.48%. This compares to year-ago revenues of $235.87 million. The company has topped consensus revenue estimates four times over the last four quarters.Medifast shares have lost about 72.4% since the beginning of the year versus the S&P 500's gain of 20.1%.While Medifast has underperformed the market so far this year, the question ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/hYDVEF34jJNULlluFRTwjg--~B/aD05MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/hYDVEF34jJNULlluFRTwjg--~B/aD05MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medifast-med-beats-q3-earnings-224507519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MED"],"gpt_icon":0},{"id":"2481686685","title":"Medifast: Q3 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2481686685","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481686685?lang=en_us&edition=fundamental","pubTime":"2024-11-05 05:45","pubTimestamp":1730756722,"startTime":"0","endTime":"0","summary":"BALTIMORE  — BALTIMORE  — Medifast Inc.  on Monday reported profit of $1.1 million in its third quarter.On a per-share basis, the Baltimore-based company said it had profit of 10 cents. Earnings, adjusted for non-recurring costs and amortization costs, came to 35 cents per share.The weight-loss company posted revenue of $140.2 million in the period.For the current quarter ending in December, Medifast expects its per-share earnings to range from 10 cents to 65 cents.The company said it expects revenue in the range of $100 million to $120 million for the fiscal fourth quarter.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medifast-q3-earnings-snapshot-214522858.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MED"],"gpt_icon":0},{"id":"2481456157","title":"Medifast (NYSE:MED) Posts Better-Than-Expected Sales In Q3 But Quarterly Guidance Underwhelms","url":"https://stock-news.laohu8.com/highlight/detail?id=2481456157","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481456157?lang=en_us&edition=fundamental","pubTime":"2024-11-05 05:36","pubTimestamp":1730756188,"startTime":"0","endTime":"0","summary":"Wellness company Medifast  reported Q3 CY2024 results exceeding the market’s revenue expectations , but sales fell 40.6% year on year to $140.2 million. On the other hand, next quarter’s revenue guidance of $110 million was less impressive, coming in 16.4% below analysts’ estimates. Its GAAP profit of $0.10 per share was also 153% above analysts’ consensus estimates.Revenue: $140.2 million vs analyst estimates of $138.2 million . “Medical innovation has transformed the weight loss industry, so at Medifast we’re creating a health and wellness business of the future by meeting the unique needs of customers regardless of their approach to their health goals,” said Dan Chard, Chairman & CEO.Known for its Optavia program that combines portion-controlled meal replacements with coaching, Medifast  has a broad product portfolio of bars, snacks, drinks, and desserts for those looking to lose weight or consume healthier foods.This quarter, Medifast’s revenue fell 40.6% year on year to $140.2 mil","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/zdquxXqvluqz4pjwDBJIkQ--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/add46d51010cdba90e56c97fa248b9f6","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/zdquxXqvluqz4pjwDBJIkQ--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/add46d51010cdba90e56c97fa248b9f6"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medifast-nyse-med-posts-better-213628998.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MED","NYSE"],"gpt_icon":0},{"id":"2481552001","title":"Medifast Inc: on Oct 30, Terminated Credit Agreement, Dated April 13, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2481552001","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481552001?lang=en_us&edition=fundamental","pubTime":"2024-11-05 05:23","pubTimestamp":1730755410,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nFWN3MB122:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","BK4532","MED"],"gpt_icon":0},{"id":"2481554470","title":"Medifast Q3 2024 Adj. EPS $0.35 Beats $(0.28) Estimate, Sales $140.163M Beat $134.150M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2481554470","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481554470?lang=en_us&edition=fundamental","pubTime":"2024-11-05 05:07","pubTimestamp":1730754429,"startTime":"0","endTime":"0","summary":"Medifast (NYSE:MED) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $(0.28) by 225 percent.  The company reported quarterly sales of $140.163 million which beat the analyst","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41727310/medifast-q3-2024-adj-eps-0-35-beats-0-28-estimate-sales-140-163m-beat-134-150m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Medifast Q3 2024 Adj. EPS $0.35 Beats $(0.28) Estimate, Sales $140.163M Beat $134.150M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MED"],"gpt_icon":0},{"id":"2481554230","title":"BRIEF-Medifast Q3 EPS USD 0.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2481554230","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481554230?lang=en_us&edition=fundamental","pubTime":"2024-11-05 05:05","pubTimestamp":1730754346,"startTime":"0","endTime":"0","summary":"Nov 04 (Reuters) - Medifast Q3 basic EPS USD 0.1. * Q3 gross profit USD 105.674 million * Q3 net income USD 1.129 million * Q3 income from operations USD 2.106 million * Q3 revenue USD 140.163 million * outlook Q4 EPS USD -0.65 to -0.1 * outlook Q4 revenue USD 100-120 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MED","USD"],"gpt_icon":0},{"id":"2481646550","title":"Medifast Inc: Qtrly Adjusted Earnings per Share of $0.35","url":"https://stock-news.laohu8.com/highlight/detail?id=2481646550","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481646550?lang=en_us&edition=fundamental","pubTime":"2024-11-05 05:05","pubTimestamp":1730754303,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nTUA69RLTP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","MED","BK4532"],"gpt_icon":0},{"id":"2481256832","title":"Medifast Announces Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2481256832","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481256832?lang=en_us&edition=fundamental","pubTime":"2024-11-05 05:05","pubTimestamp":1730754300,"startTime":"0","endTime":"0","summary":"BALTIMORE, November 04, 2024----Medifast , the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA, today reported results for the third quarter ended September 30, 2024.Revenue of $140.2 million, with revenue per active earning coach of $4,672. Selling, general, and administrative expenses  decreased 31.8% to $103.6 million compared to $151.9 million for the third quarter of 2023. The decrease in SG&A was primarily due to a $38.2 million decrease in OPTAVIA coach compensation on fewer active earning coaches and lower volumes and $5.0 million of reduced costs for coach-related events, including convention. As a percentage of revenue, SG&A increased 950 basis points year-over-year t","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ua7qESS61tyf.dALQ8mcbA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/a4fa8c4b8cf15c9fdcbf914ff9a1439a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ua7qESS61tyf.dALQ8mcbA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/a4fa8c4b8cf15c9fdcbf914ff9a1439a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medifast-announces-third-quarter-2024-210500229.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MED","BK4532","BK4183"],"gpt_icon":0},{"id":"2480313950","title":"Medifast Q3 2024 Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2480313950","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480313950?lang=en_us&edition=fundamental","pubTime":"2024-11-04 06:35","pubTimestamp":1730673300,"startTime":"0","endTime":"0","summary":"Medifast  is scheduled to announce Q3 earnings results on Monday, November 4th, after market close. The consensus EPS Estimate is -$0.19 and the consensus Revenue Estimate is $138.15M . Over the last 2 years, MED has beaten EPS estimates 88% of the time and has beaten revenue estimates 88% of the time.  Over the last 3 months, EPS estimates have seen 2 upward revisions and 0 downward. Revenue estimates have seen 0 upward revisions and 2 downward.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4235243-medifast-q3-2024-earnings-preview","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["MED"],"gpt_icon":0},{"id":"2480363071","title":"Medifast (MED) To Report Earnings Tomorrow: Here Is What To Expect","url":"https://stock-news.laohu8.com/highlight/detail?id=2480363071","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480363071?lang=en_us&edition=fundamental","pubTime":"2024-11-03 15:10","pubTimestamp":1730617814,"startTime":"0","endTime":"0","summary":"Wellness company Medifast  will be reporting results tomorrow after market hours. Here’s what investors should know.Medifast missed analysts’ revenue expectations by 3.2% last quarter, reporting revenues of $168.6 million, down 43.1% year on year. It was a slower quarter for the company, with revenue guidance for next quarter missing analysts’ expectations and a miss of analysts’ earnings estimates.Is Medifast a buy or sell going into earnings?This quarter, analysts are expecting Medifast’s revenue to decline 41.4% year on year to $138.2 million, a further deceleration from the 39.6% decrease it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.19 per share.When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen a","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/zdquxXqvluqz4pjwDBJIkQ--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/add46d51010cdba90e56c97fa248b9f6","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/zdquxXqvluqz4pjwDBJIkQ--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/add46d51010cdba90e56c97fa248b9f6"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medifast-med-report-earnings-tomorrow-071014003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MED","HLF"],"gpt_icon":0},{"id":"2480890725","title":"Medifast Inc    expected to post a loss of 28 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2480890725","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480890725?lang=en_us&edition=fundamental","pubTime":"2024-11-02 11:50","pubTimestamp":1730519445,"startTime":"0","endTime":"0","summary":"* Medifast Inc     is expected to show a fall in quarterly revenue when it reports  results on November 4 for the period ending September 30 2024   * The Owings Mills Maryland-based  company is expect","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Medifast Inc    expected to post a loss of 28 cents a share - Earnings Preview","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MED"],"gpt_icon":0},{"id":"2480287836","title":"Medifast Gears Up for Q3 Earnings: Here's What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2480287836","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480287836?lang=en_us&edition=fundamental","pubTime":"2024-11-01 21:51","pubTimestamp":1730469060,"startTime":"0","endTime":"0","summary":"Medifast, Inc. MED is likely to register a decrease in both top and bottom lines when it reports third-quarter 2024 earnings on Nov. 4. The Zacks Consensus Estimate for revenues is pegged at $135.5 million, which indicates a 42.6% decline from the year-ago period.The consensus mark for the bottom line has remained unchanged in the past 30 days at a loss of 15 cents, indicating a substantial decline from the prior-year quarter’s $2.12. MED has a trailing four-quarter earnings surprise of 64.5%, on average and delivered 155.6% for the same in the last reported quarter.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Things to Consider Ahead of MED’s Upcoming Results. Our proven model doesn’t conclusively predict an earnings beat for Medifast this time around. The combination o","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/VCILzt0LKKaSV5FPHCcbXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/829e973ee4e0f9b8c53ec82f52e62f8e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/VCILzt0LKKaSV5FPHCcbXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/829e973ee4e0f9b8c53ec82f52e62f8e"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medifast-gears-q3-earnings-heres-135100025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MED"],"gpt_icon":0},{"id":"2480876885","title":"Craig-Hallum Keeps Their Buy Rating on REPRO-MED Systems (KRMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2480876885","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480876885?lang=en_us&edition=fundamental","pubTime":"2024-11-01 21:08","pubTimestamp":1730466529,"startTime":"0","endTime":"0","summary":"In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on REPRO-MED Systems (KRMD – Research Report). The compan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/craig-hallum-keeps-their-buy-rating-on-repro-med-systems-krmd-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/craig-hallum-keeps-their-buy-rating-on-repro-med-systems-krmd-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MED","KRMD"],"gpt_icon":0},{"id":"2479587964","title":"SPYRAL HTN-ON MED study shows significant, consistent, long-term blood pressure lowering effect at two years","url":"https://stock-news.laohu8.com/highlight/detail?id=2479587964","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479587964?lang=en_us&edition=fundamental","pubTime":"2024-10-29 02:15","pubTimestamp":1730139300,"startTime":"0","endTime":"0","summary":"Company commits to advancing clinical data for Symplicity with the SPYRAL Gemini clinical trial and expansion of the GSR-DEFINE clinical trial. \"These findings are a key step toward informing the medical community of the long-term effectiveness with radiofrequency renal denervation as a treatment for uncontrolled hypertension,\" stated Dr. David Kandzari, Chief of Piedmont Heart Institute and Cardiovascular Services and lead principal investigator of the SPYRAL HTN-ON MED trial. \"Importantly, at two years, we continue to see Symplicity is safe and consistent with clinically meaningful and significant blood pressure reductions. These data further substantiate sustained blood pressure reductions consistently observed in across theSPYRAL and Global Symplicity clinical programs.\". The two-year data is consistent with other long-term data for Symplicity RDN, demonstrating clinically meaningful, consistent and sustained blood pressure reductions.1,2 At two years, the data showed:. Significant","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ahRTR9QSwQTyFpm33uxrxw--~B/aD0xMDk7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/63f853ff89c43e577cf5d2cb13b9aad2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ahRTR9QSwQTyFpm33uxrxw--~B/aD0xMDk7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/63f853ff89c43e577cf5d2cb13b9aad2"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/spyral-htn-med-study-shows-181500271.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/spyral-htn-med-study-shows-181500271.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0211326755.USD","BK4588","MED","RDN","LU0154245673.USD","LU1989764664.SGD","IE00BFXG1179.USD","LU0496365809.HKD","LU0154245756.USD","BK4183","ON","LU1989764748.USD","LU1571399168.USD","BK4532","LU2023251221.USD","LU2089284900.SGD","LU0162691827.USD","LU1291159041.SGD","IE00B3T34201.USD","BK4566","IE00BQXX3F31.USD","LU1989771016.USD","LU2028103732.USD","LU0158827948.USD","LU0158827781.USD","LU0208291251.USD","BK4229","MDT","LU0976567544.SGD","LU0211331839.USD","LU0211326839.USD","LU0072461881.USD","LU2111349929.HKD","LU2271345857.HKD","IE00BQXX3C00.GBP","LU0320765489.SGD","LU0070302665.USD","LU2089283258.USD","BK4082","BK4195","IE00BQXX3D17.EUR","BK4533","BK4585"],"gpt_icon":0},{"id":"2478626447","title":"Galderma Brings Together Over 650 Healthcare Professionals from Asia-Pacific to Elevate Knowledge of Future Aesthetic Trends","url":"https://stock-news.laohu8.com/highlight/detail?id=2478626447","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478626447?lang=en_us&edition=fundamental","pubTime":"2024-10-25 13:00","pubTimestamp":1729832400,"startTime":"0","endTime":"0","summary":"Galderma convenes a new edition of the Galderma Aesthetic Injector Network  event in the Asia-Pacific region , which will be the largest to date, bringing together more than 650 healthcare professionals  across 14 countries and regions. Titled ‘Embarking on the NEXT Aesthetic Journeys’, GAIN JPAC will explore the six trends identified in the ‘NEXT by Galderma’ report to help HCPs stay on top of evolving aesthetic trends1. GAIN is a unique community of highly trained, clinically proficient aesthetic practitioners, committed to delivering a premium experience to their clients. With one of the highest demands for aesthetics,2,3 Asia-Pacific houses some of Galderma’s fastest growing markets, where sales have fueled the company’s strong performance across product categories. There have been multiple successes in the region already this year, with launches in many key aesthetic products includin","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/tr5n50iQgryE164Xl28lFQ--~B/aD0yNTE7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/eeb0fa28ec849ee029040ba1011e1b3a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/tr5n50iQgryE164Xl28lFQ--~B/aD0yNTE7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/eeb0fa28ec849ee029040ba1011e1b3a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/galderma-brings-together-over-650-050000365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4135","GDERF","BK4532","BK4183","GAIN","GALDY","BK4007","MED","HCSG","BK4137"],"gpt_icon":0},{"id":"2477816082","title":"Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2477816082","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477816082?lang=en_us&edition=fundamental","pubTime":"2024-10-22 04:05","pubTimestamp":1729541100,"startTime":"0","endTime":"0","summary":"BALTIMORE, October 21, 2024----Medifast , the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA, will announce financial results for the third quarter ended September 30, 2024 on Monday, November 4, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.Medifast  is the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple yet comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA's holistic solution includes lifestyle plans with clinically proven health benefits, scientifically developed products, and a framework for habit creation – all reinforced by independent coach support for customers on their weight loss journeys. Through its collabora","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/LJ21cpUOdQtJ_DDAFbknDQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/664afeb205d8bada553fea8e82b005a2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/LJ21cpUOdQtJ_DDAFbknDQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/664afeb205d8bada553fea8e82b005a2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medifast-announce-financial-results-third-200500178.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","BK4183","MED"],"gpt_icon":0},{"id":"2475360803","title":"Two bidders through to I-MED next phase; final bids due November 29","url":"https://stock-news.laohu8.com/highlight/detail?id=2475360803","media":"The Australian Financial Review","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475360803?lang=en_us&edition=fundamental","pubTime":"2024-10-14 15:38","pubTimestamp":1728891480,"startTime":"0","endTime":"0","summary":"With six weeks left until binding offers are due, two motivated bidders are in the second phase of the $4 billion auction for I-MED, the country’s largest radiology business.Street Talk understands Bain Capital, which has made plenty of money on similar assets globally, is working through final due diligence and funding requirements with the help of financial adviser Bank of America.Loading...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.afr.com/street-talk/two-bidders-through-to-i-med-next-phase-final-bids-due-november-29-20241014-p5ki2r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"afr_stock","symbols":["BK4183","BK4532","MED"],"gpt_icon":0},{"id":"2474271178","title":"Medifast Inc (MED) Q2 2024 Earnings Call Transcript Highlights: Navigating Challenges and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2474271178","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474271178?lang=en_us&edition=fundamental","pubTime":"2024-10-10 01:00","pubTimestamp":1728493233,"startTime":"0","endTime":"0","summary":"Revenue: $168.6 million, a decrease of 43.1% year-over-year.Gross Profit: $123.4 million, a decrease of 41.4% year-over-year.Gross Profit Margin: Improved by 210 basis points to 73.2%.Non-GAAP Adjusted Gross Profit Margin: 74.8%, an increase of 370 basis points from the previous year.Net Loss: $8.2 million or $0.75 per diluted share.Non-GAAP Adjusted Net Income: $10.1 million or $0.92 per diluted share.Active Earning OPTAVIA Coaches: Approximately 33,900, a decrease of 36.2% from the previous year.Average Revenue per Active Earning OPTAVIA Coach: $4,972, a decline of 10.9% year-over-year.Cash, Cash Equivalents, and Investments: $163.5 million, up from $150 million as of December 31, 2023.Third Quarter Revenue Guidance: Expected to range from $125 million to $145 million.Third Quarter Loss Per Share Guidance: Expected to range from $0.05 to $0.70.GuruFocus has detected 4 Warning Signs with MED.Medifast Inc  is strategically pivoting to address a larger market, projected to be over six t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medifast-inc-med-q2-2024-170033701.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MED"],"gpt_icon":1},{"id":"2474244915","title":"VSee Health Co-CEO Among Keynote Speakers at iA-MED 2024: Future of Artificial Intelligence","url":"https://stock-news.laohu8.com/highlight/detail?id=2474244915","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474244915?lang=en_us&edition=fundamental","pubTime":"2024-10-09 20:00","pubTimestamp":1728475200,"startTime":"0","endTime":"0","summary":"Symposium for healthcare professionals assembles international experts to discuss digital health and AI applications to transform the practice of healthcare. BOCA RATON, Fla., October 09, 2024----VSee Health, Inc. , a provider of comprehensive telehealth services that customize workflow streams and enhance patient care, announced today that co-CEO Milton Chen, PhD, will be a keynote speaker at iA-Med 2024, a groundbreaking symposium dedicated to exploring the latest advancements in artificial intelligence  for healthcare professionals. Presented by ProntoMedic, an early-stage incubator, the event will take place at Auditorio FEPADE in San Salvador on October 16, 2024. Attendees include a diverse audience of physicians, nurses, administrative health professionals, students and representatives from hospitals, pharmaceutical companies and laboratories.Milton Chen, PhD, founder of VSee Health. Dr. Chen is a leading voice in telemedicine technology, impacting underserved communities globall","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/j9Bdz7ptDqL5hpskHkC1Aw--~B/aD00ODA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f88e5b36c3f3b9cf9c3da46d2d96f888","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/j9Bdz7ptDqL5hpskHkC1Aw--~B/aD00ODA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f88e5b36c3f3b9cf9c3da46d2d96f888"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vsee-health-co-ceo-among-120000543.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","BK4532","VSEE","ICU","VSEEW","MED","BK4167","BK4183"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.medifastinc.com","stockEarnings":[{"period":"1week","weight":0.0544},{"period":"1month","weight":0.0201},{"period":"3month","weight":-0.072},{"period":"6month","weight":-0.2464},{"period":"1year","weight":-0.731},{"period":"ytd","weight":-0.7202}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.","yearOnYearQuotes":[{"month":1,"riseRate":0.419355,"avgChangeRate":0.065009},{"month":2,"riseRate":0.483871,"avgChangeRate":0.027412},{"month":3,"riseRate":0.354839,"avgChangeRate":-0.00571},{"month":4,"riseRate":0.612903,"avgChangeRate":0.037332},{"month":5,"riseRate":0.451613,"avgChangeRate":0.080572},{"month":6,"riseRate":0.387097,"avgChangeRate":0.023769},{"month":7,"riseRate":0.612903,"avgChangeRate":0.094382},{"month":8,"riseRate":0.354839,"avgChangeRate":-0.031563},{"month":9,"riseRate":0.387097,"avgChangeRate":-0.022453},{"month":10,"riseRate":0.516129,"avgChangeRate":0.043184},{"month":11,"riseRate":0.451613,"avgChangeRate":0.011854},{"month":12,"riseRate":0.466667,"avgChangeRate":0.023192}],"exchange":"NYSE","name":"Medifast","nameEN":"Medifast"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Medifast(MED),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Medifast(MED) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Medifast,MED,Medifast股票,Medifast股票老虎,Medifast股票老虎国际,Medifast行情,Medifast股票行情,Medifast股价,Medifast股市,Medifast股票价格,Medifast股票交易,Medifast股票购买,Medifast股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Medifast(MED),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Medifast(MED) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction